Mucosal vaccines: NKT cells help fight flu

Nature Reviews Immunology

Volumn 8, Issue 6, 2008, Pages

  Bird, Lucy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; INFLUENZA VACCINE;

ARTICLE; CELL COUNT; CELL FUNCTION; COMBINATION CHEMOTHERAPY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MUCOSAL IMMUNITY; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; VIRUS STRAIN;

EID: 44349088353     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2345     Document Type: Article

References (1)

1. Kamijuku, H. et al. Mechanism of NKT cell activation by intranasal coadministration of α-galactosylceramide, which can induce cross-protection against influenza viruses. Mucosal Immunol. 1, 208-218 (2008)